Sophie Maïga

2.2k citations

36 papers · 1.3k indexed · h-index 20

Co-authors: Martine Amiot Catherine Pellat‐Deceunynck Philippe Moreau Steven Le Gouill Géraldine Descamps Patricia Gomez‐Bougie Cyrille Touzeau Régis Bataille
Topics: Multiple Myeloma Research and Treatments (16 papers)Ubiquitin and proteasome pathways (11 papers)Protein Degradation and Inhibitors (9 papers)
Cited by: Hematology Genetics Oncology
Journals: SHILAP Revista de lepidopterologíaBlood The Journal of Immunology
Partner nations: France United States Mali

In The Last Decade

Sophie Maïga

35 papers receiving 1.3k citations

Peers

Countries citing papers authored by Sophie Maïga

Since Specialization

Citations

This map shows the geographic impact of Sophie Maïga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Maïga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Maïga more than expected).

Fields of papers citing papers by Sophie Maïga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Maïga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Maïga. The network helps show where Sophie Maïga may publish in the future.

Co-authorship network of co-authors of Sophie Maïga

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Maïga. A scholar is included among the top collaborators of Sophie Maïga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Maïga. Sophie Maïga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	VDAC2 primes myeloma cells for BAK-dependent apoptosis and represents a novel therapeutic target 2025 ·Leukemia ·(unknown),Sophie Maïga,(unknown),Christelle Dousset,Agnès Moreau‐Aubry,Céline Bellanger,François Guillonneau,Géraldine Descamps,(unknown),Ohyun Kwon,(unknown),Philippe Moreau,David Chiron,Catherine Pellat‐Deceunynck,Cyrille Touzeau,Patricia Gomez‐Bougie	0
2	A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics 2023 ·Blood ·(unknown),Géraldine Descamps,Céline Bellanger,Christelle Dousset,Sophie Maïga,Jean-Baptiste Alberge,(unknown),(unknown),Stéphane Minvielle,(unknown),Catherine Godon,Yannick Le Bris,Benoît Tessoulin,Martine Amiot,Patricia Gomez‐Bougie,Cyrille Touzeau,Philippe Moreau,David Chiron,Agnès Moreau‐Aubry,Catherine Pellat‐Deceunynck	7
3	Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes 2020 ·Cell Death and Disease ·(unknown),Sophie Maïga,Cyrille Touzeau,Céline Bellanger,(unknown),Géraldine Descamps,Laurent Maillet,Philippe Moreau,Catherine Pellat‐Deceunynck,Patricia Gomez‐Bougie,Martine Amiot	34
4	Étude des effets indésirables lies à l'administration de Sulfadoxine-Pyrimethamine et Amodiaquine lors de la chimio prévention du paludisme saisonnier au Mali 2018 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Sulaiman Bah,(unknown),Sophie Maïga	2
5	Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways 2018 ·Journal of Hematology & Oncology ·Benoît Tessoulin,Agnès Moreau‐Aubry,Géraldine Descamps,Patricia Gomez‐Bougie,Sophie Maïga,Alban Gaignard,David Chiron,Emmanuelle Ménoret,Steven Le Gouill,Philippe Moreau,Martine Amiot,Catherine Pellat‐Deceunynck	35
6	Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells 2017 ·International Journal of Molecular Sciences ·(unknown),Géraldine Descamps,Sophie Maïga,Benoît Tessoulin,(unknown),(unknown),David Chiron,Philippe Moreau,Steven Le Gouill,Martine Amiot,Catherine Pellat‐Deceunynck,Agnès Moreau‐Aubry	3
7	Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models 2016 ·Molecular Cancer Therapeutics ·Elizabeth A. Punnoose,Joel Johansson,Franklin Peale,Erwin R. Boghaert,Lisa D. Belmont,Nguyen Tan,A. Young,Michael J. Mitten,Ellen Ingalla,Walter C. Darbonne,Anatol Oleksijew,Paul Tapang,Yue Peng,Jason Oeh,Leslie Lee,Sophie Maïga,Wayne J. Fairbrother,Martine Amiot,Andrew J. Souers,Deepak Sampath	223
8	Regular Article LYMPHOID NEOPLASIA Microenvironment-dependent proliferation and mitochondrial priming loss in mantle cell lymphoma is overcome by anti-CD20 2016 ·Blood ·David Chiron,Céline Bellanger,(unknown),Benoît Tessoulin,Christelle Dousset,Sophie Maïga,Philippe Moreau,(unknown),Valérie Trichet,Selina Chen‐Kiang,Cyrille Touzeau,Steven Le Gouill,Martine Amiot,Catherine Pellat‐Deceunynck	2
9	Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK 2014 ·Cell Death and Disease ·Carole Brosseau,Christelle Dousset,Cyrille Touzeau,Sophie Maïga,Philippe Moreau,Martine Amiot,Steven Le Gouill,Catherine Pellat‐Deceunynck	7
10	Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups 2014 ·Cancer Biology & Therapy ·Patricia Gomez‐Bougie,(unknown),Sophie Maïga,Catherine Godon,(unknown),Catherine Pellat‐Deceunynck,Philippe Moreau,Martine Amiot	21
11	RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53 abnormal myeloma cells independently of the p53 pathway 2014 ·BMC Cancer ·Sylvanie Surget,Géraldine Descamps,Carole Brosseau,Vincent Normant,Sophie Maïga,Patricia Gomez‐Bougie,(unknown),Catherine Godon,Marie C. Béné,Philippe Moreau,Steven Le Gouill,Martine Amiot,Catherine Pellat‐Deceunynck	19
12	Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells 2013 ·Blood Cancer Journal ·David Chiron,Sophie Maïga,Sylvanie Surget,Géraldine Descamps,Patricia Gomez‐Bougie,S Traoré,Nelly Robillard,Philippe Moreau,Steven Le Gouill,R Bataille,Martine Amiot,Catherine Pellat‐Deceunynck	24
13	Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction 2013 ·Leukemia ·Paola Storti,Marina Bolzoni,Gaetano Donofrío,Irma Airoldi,Daniela Guasco,Denise Toscani,E Martella,Mirca Lazzaretti,Cecilia Mancini,Luca Agnelli,K. D. Patrene,Sophie Maïga,Valentina Franceschi,Simona Colla,Judith Anderson,Antonino Neri,Martine Amiot,Franco Aversa,G. David Roodman,Nicola Giuliani	89
14	Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma 2013 ·British Journal of Cancer ·Sophie Maïga,Patricia Gomez‐Bougie,Stéphanie Bonnaud,Catherine Gratas,Philippe Moreau,Steven Le Gouill,Catherine Pellat‐Deceunynck,Martine Amiot	17
15	Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells 2012 ·Blood Cells Molecules and Diseases ·David Chiron,Sophie Maïga,Géraldine Descamps,Philippe Moreau,Steven Le Gouill,Séverine Marionneau‐Lambot,(unknown),Jérôme Moreaux,Bernard Klein,Régis Bataille,Martine Amiot,Catherine Pellat‐Deceunynck	22
16	The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction 2012 ·British Journal of Cancer ·Géraldine Descamps,Patricia Gomez‐Bougie,Jérôme Tamburini,Alexa S. Green,Didier Bouscary,Sophie Maïga,Philippe Moreau,Steven Le Gouill,Catherine Pellat‐Deceunynck,Martine Amiot	46
17	A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines 2010 ·Haematologica ·Jérôme Moreaux,Bernard Klein,Régis Bataille,Géraldine Descamps,Sophie Maïga,Dirk Hose,(unknown),Anna Jauch,Thierry Rème,M Jourdan,Martine Amiot,Catherine Pellat‐Deceunynck	124
18	IL-21 Stimulates Human Myeloma Cell Growth through an Autocrine IGF-1 Loop 2008 ·The Journal of Immunology ·Emmanuelle Ménoret,Sophie Maïga,Géraldine Descamps,Catherine Pellat‐Deceunynck,Caroline Fraslon,(unknown),Philippe Moreau,Régis Bataille,Martine Amiot	30
19	Evaluation of antibody response to Plasmodium falciparum in children according to exposure of Anopheles gambiae s.l or Anopheles funestus vectors 2007 ·Malaria Journal ·Jean Biram Sarr,Franck Remoué,Badara Samb,Ibrahima Dia,(unknown),(unknown),Sophie Maïga,(unknown),(unknown),Anne‐Marie Schacht,François Simondon,Lassana Konaté,Gilles Riveau	19
20	Epidemiological survey of the main respiratory viruses of small ruminants in Mali. 1992 ·Revue d’élevage et de médecine vétérinaire des pays tropicaux ·Sophie Maïga,(unknown)	4

About Sophie Maïga

Sophie Maïga is a scholar working on Hematology, Molecular Biology and Cancer Research, having authored 36 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (16 papers), Ubiquitin and proteasome pathways (11 papers) and Protein Degradation and Inhibitors (9 papers). The work is most often cited by research in Hematology (517 citations), Genetics (201 citations) and Oncology (425 citations). Sophie Maïga has collaborated with scholars based in France, United States and Mali. Frequent co-authors include Martine Amiot, Catherine Pellat‐Deceunynck, Philippe Moreau, Steven Le Gouill, Géraldine Descamps, Patricia Gomez‐Bougie, Cyrille Touzeau, Régis Bataille, Benoît Tessoulin and Christelle Dousset. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact